9 Results for "

Macitentan

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Macitentan" in MCE Product Catalog:

14
14 Cited Publications
Cat. No.: HY-14184
CAS No.: 441798-33-0
Purity:  99.85%
Synonyms: ACT-064992
Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15895
CAS No.: 1103522-45-7
Purity:  99.98%
Synonyms: ACT-132577
Target:  

Endothelin Receptor

Aprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is an orally active dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. Aprocitentan is an antihypertensive agent .
loading...
    loading...
Cat. No.: HY-15895S
CAS No.: 2748196-51-0
Synonyms: ACT-132577-d4
Aprocitentan-d4 is a deuterium labeled Aprocitentan. Aprocitentan is a major and pharmacologically active metabolite of Macitentan. Aprocitentan is an orally active dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively. Aprocitentan is an antihypertensive agent .
loading...
    loading...
Cat. No.: HY-14184R
CAS No.: 441798-33-0
Synonyms: ACT-064992 (Standard)
Macitentan (Standard) is the analytical standard of Macitentan. This product is intended for research and analytical applications. Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) .
loading...
    loading...
Cat. No.: HY-14184S
CAS No.: 1258428-05-5
Purity:  98.03%
Synonyms: ACT-064992-d4
Macitentan-d4 is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) .
loading...
    loading...
Cat. No.: HY-14184A
CAS No.: 556797-16-1
Purity:  99.35%
Target:  

Endothelin Receptor

Macitentan n-butyl analogue is a n-butyl analogue of Macitentan. Macitentan is an orally active, non-peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).
loading...
    loading...
Cat. No.: HY-135500
CAS No.: 1433875-14-9
Target:  

Endothelin Receptor

Research Areas:  

Endocrinology

ACT-373898 is an inactive carboxylic acid metabolite of Macitentan. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist .
loading...
    loading...
Cat. No.: HY-131996S
Synonyms: Macitentan impurity B-d4
N-Despropyl macitentan-d4 is the deuterium-labeled N-Despropyl macitentan (HY-131996).
loading...
    loading...
Cat. No.: HY-15895R
CAS No.: 1103522-45-7
Synonyms: ACT-132577 (Standard)
Aprocitentan (Standard) is the analytical standard of Aprocitentan. This product is intended for research and analytical applications. Aprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively .
loading...
    loading...